Foresite Capital Management IV, LLC has filed 29 insider transactions across 1 company since February 2026.
Most recent transaction: a transaction of 1340878 shares of Eikon Therapeutics, Inc. ($EIKN) on February 04, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 1340878 | $0.00 | 1,340,878.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 335521 | $0.00 | 1,676,399.0000 | 0 | 25.02% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 37855 | $0.00 | 1,714,254.0000 | 0 | 2.26% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 229428 | $0.00 | 1,943,682.0000 | 0 | 13.38% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 697885 | $0.00 | 697,885.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 37855 | $0.00 | 735,740.0000 | 0 | 5.42% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 1626 | $0.00 | 737,366.0000 | 0 | 0.22% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 67207 | $0.00 | 804,573.0000 | 0 | 9.11% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 458855 | $0.00 | 1,263,428.0000 | 0 | 57.03% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 348942 | $0.00 | 348,942.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 37855 | $0.00 | 386,797.0000 | 0 | 10.85% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 922 | $0.00 | 387,719.0000 | 0 | 0.24% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 38133 | $0.00 | 425,852.0000 | 0 | 9.84% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Common Stock | 408725 | $0.00 | 408,725.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | P | Common Stock | 55555 | $18.00 | 1,318,983.0000 | 0 | 4.40% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series A Preferred Stock | 10000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series A-1 Preferred Stock | 2502252 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series A-1 Preferred Stock | 5204684 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series A-1 Preferred Stock | 2602342 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series B-1 Preferred Stock | 282317 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series B-1 Preferred Stock | 282317 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series B-1 Preferred Stock | 282317 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series B-1 Preferred Stock | 3048192 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series C Preferred Stock | 12123 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series C Preferred Stock | 6878 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series C-1 Preferred Stock | 501219 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series C-1 Preferred Stock | 284392 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series D Preferred Stock | 1711025 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | Foresite Capital Management IV, LLC | TenPercentOwner | C | Series D Preferred Stock | 3422051 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |